Scholarlink

<p>pH-sensitive nanoparticles offer a promising strategy to improve therapeutic outcomes while minimizing systemic toxicity. In this study, poly(2-(diethylamino)ethyl acrylamide)-grafted chitosan (CHS-g-PDEAEAm) copolymers with various compositions were synthesized via a microwave-induced method and developed as pH-responsive nanocarriers for erlotinib (ET), a hydrophobic anticancer drug. The successful grafting of PDEAEAm onto the CHS backbone was confirmed by FTIR, <sup>1</sup>H-NMR, and <sup>13</sup>C-NMR analyses. Subsequently, ET-loaded CHS-g-PDEAEAm nanoparticles (NPs) were fabricated, and their physicochemical properties, both ET-loaded and unloaded, were systematically characterized using TEM/FE-SEM, DLS, FTIR, XRD, BET, TGA, and DSC analyses. The obtained NPs exhibited high ET entrapment efficiency, satisfactory stability, and a sustained, pH-dependent drug release profile, with slower release at physiological pH and accelerated release under acidic conditions. Furthermore, ET release was influenced by the grafting percentage, and CHS-g-PDEAEAm@ET NPs displayed a slower ET release compared to CHS@ET NPs. ET release from most NPs followed Higuchi-type diffusion-controlled kinetics. In vitro cytotoxicity studies revealed good biocompatibility of CHS-g-PDEAEAm NPs toward L-929 fibroblast cells (86.89% cell viability at 200&#xa0;μg/mL), while ET-loaded NPs demonstrated pronounced anticancer activity against A-549 lung cancer cells (6.24% cell viability at 200&#xa0;μg/mL). Overall, the CHS-g-PDEAEAm NPs demonstrated favorable colloidal stability, pH-sensitivity, sustained drug release, good biocompatibility with low hemolytic activity, and promising anticancer activity, suggesting their potential applicability as nanocarriers for hydrophobic anticancer drugs.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Chitosan-graft-poly(2-(diethylamino)ethyl acrylamide) nanoparticles as a pH-sensitive nanocarrier: design, fabrication, physicochemical characterization, and controlled delivery of erlotinib

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月30日

查看全文
  • Yunus Emre Karaçoban,
  • Enes Güncüm,
  • Nuran Işıklan

摘要

pH-sensitive nanoparticles offer a promising strategy to improve therapeutic outcomes while minimizing systemic toxicity. In this study, poly(2-(diethylamino)ethyl acrylamide)-grafted chitosan (CHS-g-PDEAEAm) copolymers with various compositions were synthesized via a microwave-induced method and developed as pH-responsive nanocarriers for erlotinib (ET), a hydrophobic anticancer drug. The successful grafting of PDEAEAm onto the CHS backbone was confirmed by FTIR, 1H-NMR, and 13C-NMR analyses. Subsequently, ET-loaded CHS-g-PDEAEAm nanoparticles (NPs) were fabricated, and their physicochemical properties, both ET-loaded and unloaded, were systematically characterized using TEM/FE-SEM, DLS, FTIR, XRD, BET, TGA, and DSC analyses. The obtained NPs exhibited high ET entrapment efficiency, satisfactory stability, and a sustained, pH-dependent drug release profile, with slower release at physiological pH and accelerated release under acidic conditions. Furthermore, ET release was influenced by the grafting percentage, and CHS-g-PDEAEAm@ET NPs displayed a slower ET release compared to CHS@ET NPs. ET release from most NPs followed Higuchi-type diffusion-controlled kinetics. In vitro cytotoxicity studies revealed good biocompatibility of CHS-g-PDEAEAm NPs toward L-929 fibroblast cells (86.89% cell viability at 200 μg/mL), while ET-loaded NPs demonstrated pronounced anticancer activity against A-549 lung cancer cells (6.24% cell viability at 200 μg/mL). Overall, the CHS-g-PDEAEAm NPs demonstrated favorable colloidal stability, pH-sensitivity, sustained drug release, good biocompatibility with low hemolytic activity, and promising anticancer activity, suggesting their potential applicability as nanocarriers for hydrophobic anticancer drugs.

Graphical abstract